TY - JOUR AB - von Hippel Lindau (VHL) disease is caused by inactivation of the VHL tumor suppressor gene, resulting in formation of multiple systemic tumors. Juxtapapillary retinal capillary hemangioma (JRCH) is one of the major manifestations in VHL disease; however, treatments are challenging, especially in children. The present study reports the case of a 6‑year‑old girl with suspected VHL disease presenting with JRCH. Fluorescein angiography demonstrated marked dye leakage from the tumor. Retinal hemorrhage occurred around the tumor 7 months later. Laser photocoagulation of the tumor tissue was safely and successfully conducted without general anesthesia. The hemorrhage diminished after laser photocoagulation. Optical coherence tomography demonstrated mild resolution of an elevated lesion in JRCH with contraction of the vitreoretinal interface over the tumor. Laser photocoagulation may be considered the first‑line treatment for young patients with JRCH, although the primary physicians must have the necessary skills and be able to establish good doctor‑patient relationships, even with children. AD - Department of Ophthalmology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido 060‑8638, Japan AU - Kase,Satoru AU - Ishida,Susumu DA - 2019/05/01 DO - 10.3892/mco.2019.1824 EP - 523 IS - 5 JO - Mol Clin Oncol KW - retinal hemangioma laser photocoagulation young girl von Hippel Lindau disease PY - 2019 SN - 2049-9450 2049-9469 SP - 521 ST - Photocoagulation for juxtapapillary retinal hemangioma in a young girl: A case report T2 - Molecular and Clinical Oncology TI - Photocoagulation for juxtapapillary retinal hemangioma in a young girl: A case report UR - https://doi.org/10.3892/mco.2019.1824 VL - 10 ER -